{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:13:22Z","timestamp":1792793602527,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00702-018-1903-3","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T08:27:58Z","timestamp":1531297678000},"page":"397-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Human tyrosine hydroxylase in Parkinson\u2019s disease and in related disorders"],"prefix":"10.1007","volume":"126","author":[{"given":"Toshiharu","family":"Nagatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"issue":"10","key":"1903_CR1","doi-asserted-by":"publisher","first-page":"E1767","DOI":"10.1002\/humu.21351","volume":"31","author":"G Bademci","year":"2010","unstructured":"Bademci G, Edwards TL, Torres AL, Scott WK, Z\u00fcchner S, Martin ER, Vance JM, Wang L (2010) A rare novel mutation of the tyrosine hydroxylase gene in Parkinson disease. Hum Mutat 31(10):E1767\u2013E1771","journal-title":"Hum Mutat"},{"issue":"4","key":"1903_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2174\/187152712800792866","volume":"11","author":"G Bademci","year":"2012","unstructured":"Bademci G, Vance JM, Wang L (2012) Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 11(4):469\u2013481","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"13","key":"1903_CR3","first-page":"59","volume":"101","author":"A Barbeau","year":"1969","unstructured":"Barbeau A (1969) l-Dopa therapy in Parkinson\u2019s disease: a critical review of nine years\u2019 experience. Can Med Assoc J 101(13):59\u201368","journal-title":"Can Med Assoc J"},{"key":"1903_CR4","doi-asserted-by":"publisher","first-page":"30390","DOI":"10.1038\/srep30390","volume":"6","author":"MT Bezem","year":"2016","unstructured":"Bezem MT, Baumann A, Skj\u00e6rven L, Meyer R, Kursula P, Martinez A, Flydal MI (2016) Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme. Sci Rep 6:30390","journal-title":"Sci Rep"},{"key":"1903_CR5","first-page":"787","volume":"73","author":"W Birkmayer","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O (1961) Der l-3,4-Dioxyphenylalanin (l-DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787\u2013788","journal-title":"Wien Klin Wochenschr"},{"key":"1903_CR6","volume-title":"PKU and BH4","year":"2006","unstructured":"Blau N (ed) (2006) PKU and BH4. SPS Publications, Weinsberg"},{"key":"1903_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ng.f.136","volume":"40","author":"W Bodmer","year":"2008","unstructured":"Bodmer W, Bonilla C (2008) Common and rare variants in multifunctional susceptibility to common diseases. Nat Genet 40:695\u2013701","journal-title":"Nat Genet"},{"issue":"9","key":"1903_CR8","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/clinchem\/44.9.1897","volume":"44","author":"C Br\u00e4utigam","year":"1998","unstructured":"Br\u00e4utigam C, Wevers RA, Jansen RI, Smeitink JA, de Rijk-van Andel JF, Gabre\u00ebls FJ, Hoffmann GF (1998) Biochemical hallmarks of tyrosine hydroxylase deficiency. Clin Chem 44(9):1897\u20131904","journal-title":"Clin Chem"},{"issue":"7628","key":"1903_CR9","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0140-6736(69)90536-4","volume":"2","author":"DB Calne","year":"1969","unstructured":"Calne DB, Stern GM, Spiers AS, Laurence DR (1969) l-Dopa in idiopathic parkinsonism. Lancet 2(7628):973\u2013976","journal-title":"Lancet"},{"issue":"2","key":"1903_CR10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0031-6997(25)07428-9","volume":"11","author":"A Carlsson","year":"1959","unstructured":"Carlsson A (1959) The occurrence, distribution and physiological role of catecholamines in the brain. Pharmacol Rev 11(2):490\u2013493","journal-title":"Pharmacol Rev"},{"issue":"4596","key":"1903_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A Carlsson","year":"1957","unstructured":"Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180(4596):1200","journal-title":"Nature"},{"key":"1903_CR12","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awp084","volume":"132","author":"F Clot","year":"2009","unstructured":"Clot F, Grabli D, Cazeneuve C, Roze E, Castelnau P, Chabrol B, Landrieu P, Nguyen K, Ponsot G, Abada A, Doummar M, Damier D, Gil P, Thobois R, Ward S, Hutchinson AJ, Toutain M, Picard A, Camuzat F, Fedirko A, San E, Bouteiller C, LeGuern D, Durr E, Vadailhet A, Brice M A (2009) Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with dopa-responsive dystonia. Brain 132:1753\u20131763","journal-title":"Brain"},{"key":"1903_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2017.12.004","volume":"111","author":"E Colla","year":"2018","unstructured":"Colla E, Panattoni G, Ricci A, Rizzi C, Rota L, Carucci N, Valvano V, Gobbo F, Capsoni S, Lee MK, Cattaneo A (2018) Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons. Neurobiol Dis 111:36\u201347","journal-title":"Neurobiol Dis"},{"key":"1903_CR14","doi-asserted-by":"publisher","first-page":"e0116597","DOI":"10.1371\/journal.pone.0116597","volume":"10","author":"NA Congo Carbajosa","year":"2015","unstructured":"Congo Carbajosa NA, Corradi G, Verrilli MA, Guil MJ, Vatta MS, Gironacci MM (2015) Tyrosine hydroxylase is short-term regulated by the ubiquitin-proteasome system in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: possible implications in hypertension. PLoS One 10:e0116597","journal-title":"PLoS One"},{"issue":"11","key":"1903_CR15","first-page":"630","volume":"278","author":"GC Cotzias","year":"1968","unstructured":"Cotzias GC (1968) l-Dopa for parkinsonism. N Engl J Med 278(11):630","journal-title":"N Engl J Med"},{"issue":"7","key":"1903_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJM196902132800701","volume":"280","author":"GC Cotzias","year":"1969","unstructured":"Cotzias GC, Papavasiliou PS, Gellene R (1969) Modification of parkinsonism\u2014chronic treatment with l-dopa. N Eng J Med 280(7):337\u2013345","journal-title":"N Eng J Med"},{"issue":"1","key":"1903_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508(1):1\u201312","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1903_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analog. Psychiatry Res 1(3):249\u2013254","journal-title":"Psychiatry Res"},{"issue":"4","key":"1903_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinson\u2019s Dis 3(4):461\u2013492","journal-title":"J Parkinson\u2019s Dis"},{"issue":"3","key":"1903_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi K, Morizane A, Ono Y, Sekiguchi K, Nakagawa M, Parmer M, Takahashi J (2014) Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep 2(3):337\u2013350","journal-title":"Stem Cell Rep"},{"issue":"1","key":"1903_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1471-4159.1996.67010019.x","volume":"67","author":"S Dumas","year":"1996","unstructured":"Dumas S, Hir HL, Bodedau-P\u00e9an S, Hirsch EC, Thermes C, Mallet J (1996) New species of human tyrosine hydroxylase mRNA are produced in various amount in adrenal medulla and are overexpressed in progressive supranuclear palsy. J Neurochem 67(1):19\u201325","journal-title":"J Neurochem"},{"key":"1903_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","volume":"91","author":"PR Dunkley","year":"2004","unstructured":"Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91:1025\u20131043","journal-title":"J Neurochem"},{"issue":"21","key":"1903_CR23","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","volume":"70","author":"JL Eberling","year":"2008","unstructured":"Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70(21):1980\u20131983","journal-title":"Neurology"},{"issue":"24","key":"1903_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin im Gehirn des Menschen und ihr Verhlten bei Erkrankungen des extrapyramidalen System. Klin Wochenschr 38(24):1236\u20131239","journal-title":"Klin Wochenschr"},{"issue":"1","key":"1903_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/mds.26102","volume":"30","author":"S Fahn","year":"2015","unstructured":"Fahn S (2015) The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Mov Disord 30(1):4\u201318","journal-title":"Mov Disord"},{"key":"1903_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.biochem.68.1.355","volume":"68","author":"PF Fitzpatrick","year":"1999","unstructured":"Fitzpatrick PF (1999) Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 68:355\u2013381","journal-title":"Annu Rev Biochem"},{"key":"1903_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2015.07.004","volume":"35","author":"PF Fitzpatrick","year":"2015","unstructured":"Fitzpatrick PF (2015) Structural insights into the regulation of aromatic amino acid hydroxylation. Curr Opin Struct Biol 35:1\u20136","journal-title":"Curr Opin Struct Biol"},{"issue":"7","key":"1903_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/humu.22565","volume":"35","author":"A Fossbakk","year":"2014","unstructured":"Fossbakk A, Kleppe R, Knappskog PM, Martinez A, Haavik J (2014) Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in dopa-responsive dystonia. Hum Mutat 35(7):880\u2013890","journal-title":"Hum Mutat"},{"issue":"1","key":"1903_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbrc.2005.07.183","volume":"338","author":"H Fujisawa","year":"2005","unstructured":"Fujisawa H, Okuno S (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem Biophys Res Commun 338(1):271\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"1903_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/WNL.56.2.260","volume":"56","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ (2001) Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56:260\u2013263","journal-title":"Neurology"},{"issue":"5","key":"1903_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/jnc.12345","volume":"126","author":"DS Goldstein","year":"2013","unstructured":"Goldstein DS, Sullivan P, Holmes C, Miller GW, Alter S, Strong R, Mash DC, Kopin IJ, Sharabi Y (2013) Determination of buildup of the toxic dopamine metabolite (DOPAL) in Parkinson\u2019s disease. J Neurochem 126(5):591\u2013603","journal-title":"J Neurochem"},{"issue":"9","key":"1903_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nsb0797-578","volume":"4","author":"KE Goodwill","year":"1997","unstructured":"Goodwill KE, Sabatier C, Marks C, Raag R, Fitzpatrick PF, Stevens RC (1997) Crystal structure of tyrosine hydroxylase at 2.5 A and its implication for inherited neurodegenerative diseases. Nat Struct Biol 4(9):578\u2013585","journal-title":"Nat Struct Biol"},{"issue":"6114","key":"1903_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/326707a0","volume":"326","author":"B Grima","year":"1987","unstructured":"Grima B, Lamouroux A, Boni C, Julian J-F, Javoy-Agid F, Mallet J (1987) A single human gene encoding multiple tyrosine hydroxylase with different functional characteristics. Nature 326(6114):707\u2013711","journal-title":"Nature"},{"key":"1903_CR34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JPD-2011-11006","volume":"1","author":"K Haugarvoll","year":"2011","unstructured":"Haugarvoll K, Bindoff LA (2011) A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. J Parkinson\u2019s Dis 1:119\u2013122","journal-title":"J Parkinson\u2019s Dis"},{"key":"1903_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1468-1331.2006.01249.x","volume":"13","author":"JM Hertz","year":"2006","unstructured":"Hertz JM, Ostergaard K, Juncker I, Pedersen S, Romstad A, M\u00f8ller LB, G\u00fcttler F, Dupont E (2006) Low frequency of Parkin, tyrosine hydroxylase, and GTP cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson\u2019s disease. Eur J Neurol 13:385\u2013390","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"1903_CR36","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","volume":"18","author":"EC Hirsch","year":"2012","unstructured":"Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S210\u2013S212","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1903_CR37","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1002\/ana.10632","volume":"54","author":"GF Hoffmann","year":"2003","unstructured":"Hoffmann GF, Assmann B, Br\u00e4utigam C, Dionisi-Vici C, H\u00e4usler M, de Klert JBC, Naumann M, Steenbergen-Spanjers GCH, Strassburg H-M, Wevers RA (2003) Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 54(6):S56\u2013S65","journal-title":"Ann Neurol"},{"issue":"134","key":"1903_CR38","doi-asserted-by":"publisher","first-page":"134ra61","DOI":"10.1126\/scitranslmed.3003640","volume":"4","author":"WL Hwu","year":"2012","unstructured":"Hwu WL, Muramatsu S, Tseng SH, Tzen KY, Lee NC, Chien YH, Snyder RO, Byrne BJ, Tai CH, Wu RM (2012) Gene therapy for aromatic l-amino acid decarboxylase deficiency. Sci Transl Med 4(134):134ra61","journal-title":"Sci Transl Med"},{"issue":"3","key":"1903_CR39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0006-291X(05)80933-7","volume":"173","author":"S Ichikawa","year":"1990","unstructured":"Ichikawa S, Ichinose H, Nagatsu T (1990) Multiple mRNAs of monkey tyrosine hydroxylase. Biochem Biophys Res Commun 173(3):1331\u20131336","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1903_CR40","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/0006-291X(91)90472-J","volume":"176","author":"S Ichikawa","year":"1991","unstructured":"Ichikawa S, Sasaoka T, Nagatsu T (1991) Primary structure of mouse tyrosine hydroxylase deduced form its cDNA. Biochem Biophys Res Commun 176(3):1610\u20131616","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1903_CR41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/bbrc.1993.2024","volume":"195","author":"H Ichinose","year":"1993","unstructured":"Ichinose H, Ohye T, Fujita K, Yoshida M, Ueda S, Nagatsu T (1993) Increased heterogeneity of tyrosine hydroxylase in humans. Biochem Biophys Res Commun 195(1):158\u2013165","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"1903_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02250926","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P, Nagatsu T (1994a) Quantification of mRNA of tyrosine hydroxylase and aromatic l-amino acid decarboxylase in the substantia nigra in Parkinson\u2019s disease and schizophrenia. J Neural Transm Parkinson Dis Dement Sect 8(1\u20132):149\u2013158","journal-title":"J Neural Transm Parkinson Dis Dement Sect"},{"issue":"3","key":"1903_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/ng1194-236","volume":"8","author":"H Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T (1994b) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8(3):236\u2013242","journal-title":"Nat Genet"},{"issue":"17","key":"1903_CR44","doi-asserted-by":"publisher","first-page":"10062","DOI":"10.1074\/jbc.270.17.10062","volume":"270","author":"H Ichinose","year":"1995","unstructured":"Ichinose H, Ohye T, Matsuda Y, Hori T, Blau N, Burlina A, Rouse B, Matalon R, Fujita K, Nagatsu T (1995) Characterization of mouse and human GTP cyclohydrolase I genes: mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem 270(17):10062\u201310071","journal-title":"J Biol Chem"},{"issue":"12","key":"1903_CR45","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1515\/BC.1999.175","volume":"380","author":"H Ichinose","year":"1999","unstructured":"Ichinose H, Suzuki T, Inagaki H, Ohye T, Nagatsu T (1999) Molecular genetics of dopa-responsive dystonia. Biol Chem 380(12):1355\u20131364","journal-title":"Biol Chem"},{"issue":"2","key":"1903_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K Imamura","year":"2005","unstructured":"Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2005) Cytokine production of activated microglia and decrease in neurotrophic factors in neurons of hippocampus of Lewy body disease brain. Acta Neuropathol 109(2):141\u2013150","journal-title":"Acta Neuropathol"},{"issue":"51","key":"1903_CR47","doi-asserted-by":"publisher","first-page":"39718","DOI":"10.1074\/jbc.M110.137034","volume":"285","author":"S Ishikawa","year":"2010","unstructured":"Ishikawa S, Taira T, Takahashi-Niki K, Niki T, Ariga H, Iguchi-Ariga SM (2010) Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. J Biol Chem 285(51):39718\u201339731","journal-title":"J Biol Chem"},{"issue":"23","key":"1903_CR48","first-page":"5188","volume":"25","author":"T Ishikawa","year":"2016","unstructured":"Ishikawa T, Imamura K, Kondo T, Koshiba Y, Hara S, Ichinose H, Furujo M, Kinoshita M, Oeda T, Takahashi J, Takahashi R, Inoue H (2016) Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolic disorders. Hum Mol Genet 25(23):5188\u20135197","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1903_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0006-291X(05)80151-2","volume":"182","author":"N Iwata","year":"1992","unstructured":"Iwata N, Kobayashi K, Sasaoka T, Hidaka H, Nagatsu T (1992) Structure of the mouse tyrosine hydroxylase gene. Biochem Biophy Res Commun 182(1):348\u2013354","journal-title":"Biochem Biophy Res Commun"},{"issue":"5","key":"1903_CR50","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1469-1809.2000.6450375.x","volume":"64","author":"RJJ Janssen","year":"2000","unstructured":"Janssen RJJ, Wevers RA, H\u00e4ussler M, Luyten JA, Steenbergen-Spanjers GC, Hoffmann GF, Nagatsu T, Van den Heuvel LPJ (2000) A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 64(5):375\u2013382","journal-title":"Ann Hum Genet"},{"key":"1903_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1054-3589(08)60688-2","volume":"42","author":"T Joh","year":"1998","unstructured":"Joh T, Son JH, Tinti C, Centi B, Kim SJ, Cho S (1998) Unique and cell-type specific tyrosine hydroxylase gene expression. Adv Pharmacol 42:33\u201336","journal-title":"Adv Pharmacol"},{"issue":"3","key":"1903_CR52","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.scr.2016.10.008","volume":"17","author":"S Jung-Klawitter","year":"2016","unstructured":"Jung-Klawitter S, Blau N, Sebe A, Ebersold J, G\u00f6hring G, Opladen T (2016) Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC. Stem Cell Res 17(3):580\u2013583","journal-title":"Stem Cell Res"},{"issue":"3","key":"1903_CR53","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0006-291X(87)90742-X","volume":"146","author":"N Kaneda","year":"1987","unstructured":"Kaneda N, Kobayashi K, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a novel cDNA for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem Biophys Res Commun 146(3):971\u2013975","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1903_CR54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0896-6273(91)90061-4","volume":"6","author":"N Kaneda","year":"1991","unstructured":"Kaneda N, Sasaoka T, Kobayashi K, Kiuchi K, Nagatsu I, Kurosawa Y, Fujita K, Yokoyama M, Nomura T, Katsuki M, Nagatsu T (1991) Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron 6(4):583\u2013594","journal-title":"Neuron"},{"key":"1903_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0006-8993(93)91005-D","volume":"606","author":"A Kastner","year":"1993","unstructured":"Kastner A, Hirsch EC, Agid Y, Javoy-Agid F (1993a) Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson\u2019s disease. Brain Res 606:341\u2013345","journal-title":"Brain Res"},{"key":"1903_CR56","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1471-4159.1993.tb03616.x","volume":"61","author":"E Kastner","year":"1993","unstructured":"Kastner E, Hirsch EC, Herrero T, Javoy-Agid F, Agid Y (1993b) Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and Parkinson\u2019s and Alzheimer\u2019s disease. J Neurochem 61:1024\u20131034","journal-title":"J Neurochem"},{"key":"1903_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40734-017-0065-z","volume":"4","author":"LE Katus","year":"2017","unstructured":"Katus LE, Frucht SJ (2017) An unusual presentation of tyrosine hydroxylase deficiency. J Clin Mov Disord 4:18","journal-title":"J Clin Mov Disord"},{"key":"1903_CR58","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1073\/pnas.50.6.1085","volume":"50","author":"S Kaufman","year":"1963","unstructured":"Kaufman S (1963) The structure of the phenylalanine-hydroxylation cofactor. Proc Nat Acad Sci 50:1085\u20131093","journal-title":"Proc Nat Acad Sci"},{"issue":"12","key":"1903_CR59","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s00702-009-0304-z","volume":"116","author":"I Kawahata","year":"2009","unstructured":"Kawahata I, Tokuoka H, Parvez H, Ichinose H (2009) Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of a ubiquitin-proteasome system in PC12D cells. J Neural Transm 116(12):1571\u20131578","journal-title":"J Neural Transm"},{"key":"1903_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbrc.2015.07.125","volume":"465","author":"I Kawahata","year":"2015","unstructured":"Kawahata I, Ohtaku S, Tomioka Y, Ichinose H, Yamakuni T (2015) Dopamine or biopterin deficiency potentiates phosphorylation at Ser40 and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system. Biochem Biophys Res Commun 465:53\u201358","journal-title":"Biochem Biophys Res Commun"},{"issue":"6676","key":"1903_CR61","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori H, Yamamura S, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605\u2013608","journal-title":"Nature"},{"issue":"7","key":"1903_CR62","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/hmg\/4.7.1209","volume":"4","author":"PM Knappskog","year":"1995","unstructured":"Knappskog PM, Flatmark T, Mallet J, L\u00fcdecke B, Bartholom\u00e9 K (1995) Recessively inherited l-DOPA-responsive dystonia by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 4(7):1209\u20131212","journal-title":"Hum Mol Genet"},{"key":"1903_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2005.07.186","volume":"338","author":"K Kobayashi","year":"2005","unstructured":"Kobayashi K, Nagatsu T (2005) Molecular genetics of tyrosine 3-monooxygenase and inherited diseases. Biochem Biophys Res Commun 338:267\u2013270","journal-title":"Biochem Biophys Res Commun"},{"key":"1903_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-386525-0.00007-X","volume-title":"Primers on the autosomal nervous system","author":"K Kobayashi","year":"2012","unstructured":"Kobayashi K, Nagatsu T (2012) Tyrosine hydroxylase. In: Robertson D, Biggioni I, Burnstock G, Low PA, Paton JFR (eds) Primers on the autosomal nervous system. Academic Press\/Elsevier, Oxford, pp\u00a045\u201347"},{"issue":"16","key":"1903_CR65","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/nar\/15.16.6733","volume":"15","author":"K Kobayashi","year":"1987","unstructured":"Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a full-length cDNA clone encoding human tyrosine hydroxylase type 3. Nucleic Acids Res 15(16):733","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1903_CR66","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/oxfordjournals.jbchem.a122386","volume":"103","author":"K Kobayashi","year":"1988","unstructured":"Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1988) Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem 103(6):907\u2013912","journal-title":"J Biochem"},{"issue":"2","key":"1903_CR67","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1471-4159.1996.67020443.x","volume":"67","author":"SC Kumer","year":"1996","unstructured":"Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67(2):443\u2013462","journal-title":"J Neurochem"},{"issue":"12","key":"1903_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(SICI)1096-8628(19980328)81:2<131::AID-AJMG2>3.0.CO;2-Z","volume":"81","author":"H Kunugi","year":"1998","unstructured":"Kunugi H, Kawada Y, Hattori M, Ueki A, Otsuka M, Nanko S (1998) Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson\u2019s disease. Am J Med Genet 81(12):131\u2013133","journal-title":"Am J Med Genet"},{"issue":"2","key":"1903_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1152\/physrev.00042.2006","volume":"89","author":"R Kvetnansky","year":"2009","unstructured":"Kvetnansky R, Sabban EL, Palkovits M (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89(2):535\u2013606","journal-title":"Physiol Rev"},{"key":"1903_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00439-016-1749-4","volume":"136","author":"V Cognata La","year":"2017","unstructured":"La Cognata V, Morello G, D\u2019Agata VD, Cavallaro S (2017) Copy number variability in Parkinson\u2019s disease: assembling the puzzle through a systems biology approach. Hum Genet 136:13\u201337","journal-title":"Hum Genet"},{"issue":"12","key":"1903_CR71","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1073\/pnas.79.12.3881","volume":"79","author":"A Lamouroux","year":"1982","unstructured":"Lamouroux A, Faucon Biguet N, Samolyk D, Privat A, Salmon JC, Pujol JF, Mallet JC (1982) Identification of cDNA clones coding for rat tyrosine hydroxylase antigen. Proc Natl Acad Sci USA 79(12):3881\u20133885","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4587","key":"1903_CR72","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"10","key":"1903_CR73","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/mt.2015.122","volume":"23","author":"NC Lee","year":"2015","unstructured":"Lee NC, Muramatsu S, Chien YH, Liu WS, Wang WH, Cheng CH, Hu MK, Chen PW, Tzen KY, Byrne BJ, Hwu WL (2015) Benefits of neuronal preferential systemic gene therapy for neurotransmitter deficiency. Mol Ther 23(10):1572\u20131581","journal-title":"Mol Ther"},{"issue":"26","key":"1903_CR74","doi-asserted-by":"publisher","first-page":"17644","DOI":"10.1074\/jbc.M512194200","volume":"281","author":"IT Lehmann","year":"2006","unstructured":"Lehmann IT, Bobrovskaya L, Gordon SL, Dunkley PR, Dickson PW (2006) Differential regulation of the human tyrosine hydroxylase isoforms via hierarchical phosphorylation. J Biol Chem 281(26):17644\u201317651","journal-title":"J Biol Chem"},{"issue":"2","key":"1903_CR75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0306-4522(93)90267-J","volume":"54","author":"DA Lewis","year":"1993","unstructured":"Lewis DA, Melchitzky DS, Haycock JW (1993) Four isoforms of human tyrosine hydroxylase are expressed in human brain. Neuroscience 54(2):477\u2013492","journal-title":"Neuroscience"},{"issue":"1","key":"1903_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(94)91360-9","volume":"656","author":"DA Lewis","year":"1994","unstructured":"Lewis DA, Melchitzky DS, Haycock JW (1994) Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain. Brain Res 656(1):1\u201313","journal-title":"Brain Res"},{"issue":"3","key":"1903_CR77","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","volume":"195","author":"KG Lloyd","year":"1975","unstructured":"Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson\u2019s disease: effect of l-DOPA therapy. J Pharmacol Exp Therap 195(3):453\u2013464","journal-title":"J Pharmacol Exp Therap"},{"issue":"1","key":"1903_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00225091","volume":"95","author":"B L\u00fcdecke","year":"1995","unstructured":"L\u00fcdecke B, Dworniczak B, Bartholom\u00e9 K (1995) A point mutation in the tyrosine hydroxylase gene associated with Segawa\u2019s syndrome. Hum Genet 95(1):123\u2013125","journal-title":"Hum Genet"},{"issue":"7","key":"1903_CR79","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/hmg\/5.7.1023","volume":"5","author":"B L\u00fcdecke","year":"1996","unstructured":"L\u00fcdecke B, Knappskog PM, Clayton PT, Surtees RAH, Clelland JD, Heales SJR, Brand MP, Bartholom\u00e9 K, Flattmark T (1996) Recessively inherited l-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the the tyrosine hydroxylase gene. Hum Mol Genet 5(7):1023\u20131028","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1903_CR80","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/oxfordjournals.jbchem.a135401","volume":"98","author":"S Matsuura","year":"1985","unstructured":"Matsuura S, Sugimoto T, Murata S, Sugawara Y, Iwasaki H (1985) Stereochemistry of biopterin cofactor and facile methods for determination of the stereochemistry of a biologically active 5,6,7,8-tetrahydropterin. J Biochem 98(5):1341\u20131348","journal-title":"J Biochem"},{"issue":"2","key":"1903_CR81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21(2):195\u2013218","journal-title":"Brain Res Rev"},{"issue":"4","key":"1903_CR82","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson disease. Neuron 90(4):675\u2013691","journal-title":"Neuron"},{"issue":"3","key":"1903_CR83","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","volume":"163","author":"Y Mizuno","year":"1989","unstructured":"Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson\u2019s disease. Biochem Bophys Res Commun 163(3):1450\u20131455","journal-title":"Biochem Bophys Res Commun"},{"key":"1903_CR84","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF01244634","volume":"72","author":"M Mogi","year":"1988","unstructured":"Mogi M, Harada N, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T (1988a) Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain. J Neural Transm 72:221\u2013232","journal-title":"J Neural Transm"},{"issue":"2","key":"1903_CR85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0197-0186(88)90126-X","volume":"12","author":"M Mogi","year":"1988","unstructured":"Mogi M, Harada M, Kojima K, Inagaki H, Kondo T, Narabayashi H, Arai T, Teradaira R, Fujita K, Kiuchi K, Nagatsu T (1988b) Sandwich enzyme immunoassay of dopamine beta-hydroxylase in cerebrospinal fluid from control and Parkinsonian patients. Neurochem Int 12(2):187\u2013191","journal-title":"Neurochem Int"},{"issue":"4","key":"1903_CR86","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","volume":"1","author":"A Morizane","year":"2013","unstructured":"Morizane A, Doi D, Kikuchi T, Okita K, Hotta A, Kawasaki T, Hayashi T, Onoe H, Shiina T, Yamanaka S, Takahashi J (2013) Direct comparison of autologous and allogenic transplantation of iPS-derived neural cells in the brain of a non-human primate. Stem Cell Rep 1(4):283\u2013292","journal-title":"Stem Cell Rep"},{"issue":"3","key":"1903_CR87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/10430340252792486","volume":"13","author":"S Muramatsu","year":"2002","unstructured":"Muramatsu S, Fujimoto K, Ikeguchi K, Shizuma N, Kawasaki K, Ono F, Shen Y, Wang LJ, Mizukami H, Kume A, Matsumura M, Nagatsu I, Urano F, Ichinose H, Nagatsu T, Terano K, Nakano I, Ozawa K (2002) Behavioral recovery in a primate model of Parkinson\u2019s disease by triple transduction of cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes. Hum Gene Ther 13(3):345\u2013354","journal-title":"Hum Gene Ther"},{"issue":"9","key":"1903_CR88","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/mt.2010.135","volume":"18","author":"S Muramatsu","year":"2010","unstructured":"Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K, Kawakami T, Urabe M, Kume A, Sato T, Watanabe E, Ozawa K, Nakano I (2010) A phase I study of aromatic l-amino acid decarboxylase gene therapy for Parkinson\u2019s disease. Mol Ther 18(9):1731\u20131735","journal-title":"Mol Ther"},{"issue":"2","key":"1903_CR89","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0168-0102(91)90001-F","volume":"12","author":"T Nagatsu","year":"1991","unstructured":"Nagatsu T (1991) Genes for human catecholamine-synthesizing enzymes. Neurosci Res 12(2):315\u2013345","journal-title":"Neurosci Res"},{"key":"1903_CR90","first-page":"15","volume":"30","author":"T Nagatsu","year":"1995","unstructured":"Nagatsu T (1995) Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays Biochem 30:15\u201335","journal-title":"Essays Biochem"},{"issue":"10","key":"1903_CR91","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2183\/pjab.82.388","volume":"82","author":"T Nagatsu","year":"2006","unstructured":"Nagatsu T (2006) The catecholamine system in health and disease: relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes. Proc Jpn Acad Ser B 82(10):388\u2013415","journal-title":"Proc Jpn Acad Ser B"},{"key":"1903_CR92","first-page":"68","volume-title":"From East to West: pioneers in Parkinson\u2019s disease in Japan","author":"T Nagatsu","year":"2014","unstructured":"Nagatsu T (2014) Tyrosine hydroxylase. In: Nagatsu T, Takahashi A, Yanagisawa N, Mizuno Y, Kondo T, Takahashi R, Mezaki T, Riederer P (eds) From East to West: pioneers in Parkinson\u2019s disease in Japan. QOL Laboratory Corp, Tokyo, pp\u00a068\u201369"},{"issue":"1","key":"1903_CR93","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0742-8413(91)90196-Z","volume":"98","author":"T Nagatsu","year":"1991","unstructured":"Nagatsu T, Ichinose H (1991) Comparative studies on the structure of human tyrosine hydroxylase with those of the enzymes of various mammals. Comp Biochem Physiol C 98(1):203\u2013210","journal-title":"Comp Biochem Physiol C"},{"key":"1903_CR94","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00702-016-1596-4","volume":"123","author":"T Nagatsu","year":"2016","unstructured":"Nagatsu T, Nagatsu I (2016) Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson\u2019s disease (PD): historical overview and future prospects. J Neural Transm 123:1255\u20131278","journal-title":"J Neural Transm"},{"issue":"8","key":"1903_CR95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role of cytokines. Curr Pharm Des 11(8):999\u20131016","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1903_CR96","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S1353-8020(09)70004-5","volume":"15","author":"T Nagatsu","year":"2009","unstructured":"Nagatsu T, Sawada M (2009) l-dopa therapy for Parkinson\u2019s disease: past, present, and future. Parkinsonism Relat Disord 15(1):S3\u2013S8","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"1903_CR97","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","volume":"239","author":"T Nagatsu","year":"1964","unstructured":"Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239(9):2910\u20132917","journal-title":"J Biol Chem"},{"key":"1903_CR98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","volume":"75","author":"T Nagatsu","year":"1977","unstructured":"Nagatsu T, Kato T, Numata Y, Ikuta K, Sano M, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Hori A, Narabayashi H (1977) Phenylethanolamine N-methyltransferase activity and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta 75:221\u2013232","journal-title":"Clin Chim Acta"},{"key":"1903_CR99","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbrc.2011.03.020","volume":"407","author":"A Nakashima","year":"2011","unstructured":"Nakashima A, Mori K, Kaneko YS, Hayashi N, Nagatsu T, Ota A (2011) Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme. Biochem Biophys Res Commun 407:343\u2013347","journal-title":"Biochem Biophys Res Commun"},{"key":"1903_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00702-012-0828-5","volume":"120","author":"A Nakashima","year":"2013","unstructured":"Nakashima A, Ota A, Kaneko YS, Mori K, Nagasaki H, Nagatsu T (2013a) A possible pathophysiological role of tyrosine hydroxylase in Parkinson\u2019s disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer. J Neural Transm 120:49\u201354","journal-title":"J Neural Transm"},{"key":"1903_CR101","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-411512-5.00001-4","volume":"68","author":"A Nakashima","year":"2013","unstructured":"Nakashima A, Kaneko YS, Kodani Y, Mori K, Nagasaki H, Nagatsu T, Ota A (2013b) Intracellular stability of tyrosine hydroxylase: phosphorylation and proteasomal digestion of the enzyme. Adv Pharmacol 68:3\u201311","journal-title":"Adv Pharmacol"},{"key":"1903_CR102","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbrc.2016.03.022","volume":"427","author":"A Nakashima","year":"2016","unstructured":"Nakashima A, Ohnuma S, Kodani Y, Kaneko YS, Nagasaki H, Nagatsu T, Ota A (2016) Inhibition of deubiquitinating activity of USP14 decreases tyrosine hydroxylase phosphorylated at Ser19 in PC12D cells. Biochim Biophys Res Commun 427:598\u2013602","journal-title":"Biochim Biophys Res Commun"},{"key":"1903_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00702-016-1653-z","volume":"125","author":"A Nakashima","year":"2018","unstructured":"Nakashima A, Kodani Y, Kaneko YS, Nagasaki H, Ota A (2018) Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs. J Neural Trans 125:9\u201315","journal-title":"J Neural Trans"},{"issue":"22","key":"1903_CR104","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1021\/bi00396a007","volume":"26","author":"KL O\u2019Malley","year":"1987","unstructured":"O\u2019Malley KL, Anhalt MJ, Martin BM, Kalsoe JR, Winfield SL, Ginns EI (1987) Isolation and characterization of human tyrosine hydroxylase gene: identification of 5\u2032-alternative splice sites responsible for multiple mRNAs. Biochemistry 26(22):6910\u20136914","journal-title":"Biochemistry"},{"issue":"1","key":"1903_CR105","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/neur.1995.0009","volume":"4","author":"T Ohye","year":"1995","unstructured":"Ohye T, Ichinose H, Ogawa M, Yoshida M, Nagatsu T (1995) Alternative splicing in multiple tyrosine hydroxylase mRNA in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated parkinsonian monkeys. Neurodegeneration 4(1):157\u2013160","journal-title":"Neurodegeneration"},{"issue":"3","key":"1903_CR106","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(01)02210-8","volume":"312","author":"T Ohye","year":"2001","unstructured":"Ohye T, Ichinose H, Yoshizawa T, Kanazawa I, Nagatsu T (2001) A new splicing variant for human tyrosine hydroxylase in the adrenal medulla. Neurosci Lett 312(3):157\u2013160","journal-title":"Neurosci Lett"},{"issue":"9923","key":"1903_CR107","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi S, Grruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kellleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, Burugi\u00e8res P, Grabriel I, Abhay K, Drout X, Tani N, Kas A, Ghaleh B, Le Corvoisier P, Dolphin P, Breen DP, Mason S, Guzman NV, Mazarakis ND, Radclifffe PA, Harrop R, Kingsman SM, Rascol O, Naylor S, Baker RA, Hantraye P, Remy P, Cessaro P, Mitrophanous KA (2014) Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet 383(9923):1138\u20131146","journal-title":"Lancet"},{"issue":"3","key":"1903_CR108","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mds.870090312","volume":"9","author":"V Plant\u00e9-Bordeneuve","year":"1994","unstructured":"Plant\u00e9-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE (1994) Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson\u2019s disease. Mov Disord 9(3):337\u2013339","journal-title":"Mov Disord"},{"issue":"5321","key":"1903_CR109","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athannassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvosin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in familial Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"key":"1903_CR110","unstructured":"Reichmann H, Riederer P (1989) Biochemische Analyse der Atmugskettenkomplexe verschiedener Hirnregionen von Forschung und Technologie (BMBF). Bad Kissingen (Germany), 23\u201325 Apr, 1.2.6; p 44"},{"key":"1903_CR111","first-page":"42","volume":"5","author":"I Sano","year":"1960","unstructured":"Sano I (1960) Biochemistry of the extrapyramidal system. Shinkei Kennkyu No Shinppo (Japanese). Adv Neurol Sci 5:42\u201348 (ISSN:0001-8724)","journal-title":"Adv Neurol Sci"},{"key":"1903_CR112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1353-8020(99)00046-2","volume":"6","author":"A Sano","year":"2000","unstructured":"Sano A (2000) Biochemistry of the extrapyramidal system (translation of the reference Sano I (1960) from Japanese into English). Parkinsonism Relat Disord 6:3\u20136","journal-title":"Parkinsonism Relat Disord"},{"key":"1903_CR113","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/0006-3002(59)90652-3","volume":"32","author":"I Sano","year":"1959","unstructured":"Sano I, Gamo T, Kakimoto Y, Taniguchi K, Takesada M, Nishinuma K (1959) Distribution of catechol compounds in human brain. Biochim Biophys Acta 32:586\u2013587","journal-title":"Biochim Biophys Acta"},{"key":"1903_CR114","first-page":"3","volume":"1","author":"M Sawada","year":"2007","unstructured":"Sawada M, Imamura K, Hashizume Y, Nagatsu T (2007) Role of cytokines in inflammatory process in Parkinson\u2019s disease: interaction between dopaminergic neurons and microglia. CNS Drugs 1:3\u201310","journal-title":"CNS Drugs"},{"key":"1903_CR115","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","volume":"1","author":"AHV Schapira","year":"1989","unstructured":"Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson\u2019s disease. Lancet 1:1269","journal-title":"Lancet"},{"issue":"3","key":"1903_CR116","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.braindev.2010.10.015","volume":"33","author":"M Segawa","year":"2011","unstructured":"Segawa M (2011) Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev 33(3):195\u2013201","journal-title":"Brain Dev"},{"key":"1903_CR117","first-page":"667","volume":"24","author":"M Segawa","year":"1971","unstructured":"Segawa M, Ohmi K, Itoh S, Aoyama M, Hayakawa H (1971) Hereditary progressive basal ganglia disease with marked diurnal fluctuation (in Japanese). SHINRYO (Japanese) 24:667\u2013672","journal-title":"SHINRYO (Japanese)"},{"key":"1903_CR118","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnins.2018.00106","volume":"12","author":"J Segura-Aguilar","year":"2018","unstructured":"Segura-Aguilar J, Huenchguala S (2018) Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in Parkinson\u2019s disease. Front Neurosci 12:106","journal-title":"Front Neurosci"},{"issue":"3","key":"1903_CR119","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1089\/humc.2016.056","volume":"27","author":"HJ Stewart","year":"2016","unstructured":"Stewart HJ, Ralph GS, Fong-Wong L, Strickland I, McCloskey L, Barnes L, Blount I, Wells O, Truran CJ, Kingsman AJ, Palfi S, Mitrophanous KA (2016) Optimizing transgene configuration and protein fusions to maximize dopamine production for the gene therapy of Parkinson\u2019s disease. Human Gene Ther Clin Dev 27(3):100\u2013110","journal-title":"Human Gene Ther Clin Dev"},{"issue":"1","key":"1903_CR120","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1006\/exnr.2000.7421","volume":"161","author":"I Str\u00f6mberg","year":"2000","unstructured":"Str\u00f6mberg I, Kehr J, Andbjer B, Fuxe K (2000) Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum. Exp Neurol 161(1):154\u2013165","journal-title":"Exp Neurol"},{"issue":"8","key":"1903_CR121","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/bi00123a004","volume":"31","author":"C Sumi-Ichinose","year":"1992","unstructured":"Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T (1992) Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic l-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31(8):2229\u20132238","journal-title":"Biochemistry"},{"issue":"4","key":"1903_CR122","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663\u2013676","journal-title":"Cell"},{"issue":"5","key":"1903_CR123","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861\u2013872","journal-title":"Cell"},{"issue":"6","key":"1903_CR124","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s004390050756","volume":"102","author":"LP Heuvel Van den","year":"1998","unstructured":"Van den Heuvel LP, Luiten B, Smeitink JA, de Rijk-van Andel JF, Hyland K, Steenbergen-Spanjers GC, Janssen LP, Wevers RA (1998) A common point mutation in the tyrosine hydroxylase gene in autosomal recessive l-DOPA-responsive dystonia in the Dutch population. Human Genet 102(6):644\u2013646","journal-title":"Human Genet"},{"issue":"16 Pt2","key":"1903_CR125","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1212\/01.wnl.0000275527.35752.c5","volume":"70","author":"C Wider","year":"2008","unstructured":"Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Shorderet DF, Ghika J, Burkhard PR, Kapatos G, Hutton M, Farrer MJ, Wszolek ZK, Vingerhoets FJ (2008) Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 70(16 Pt2):1377\u20131383","journal-title":"Neurology"},{"issue":"Pt 6","key":"1903_CR126","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/brain\/awq087","volume":"133","author":"MA Willemsen","year":"2010","unstructured":"Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, Burlina A, Donati MA, Geurtz B, Grattan-Smith PJ, Haeussler M, Hoffmann GF, Jung H, de Klerk JB, van der Knaap MS, Kok F, Leuzzi V, de Lonlay P, Megarbane A, Monaghan H, Renier WO, Rondot P, Ryan MM, Seeger J, Smeitink JA, Steenbergen-Spanjers GC, Wassmer E, Weschke B, Wijburg FA, Wilcken B, Zafeiriou DI, Wevers RA (2010) Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133(Pt 6):1810\u20131822","journal-title":"Brain"},{"issue":"1","key":"1903_CR127","first-page":"29","volume":"1802","author":"KF Winklhofer","year":"2010","unstructured":"Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson\u2019s disease. Biochem Biophys Acta 1802(1):29\u201344","journal-title":"Biochem Biophys Acta"},{"issue":"7","key":"1903_CR128","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jmb.2013.12.015","volume":"426","author":"S Zhang","year":"2014","unstructured":"Zhang S, Huang T, Ilangovan U, Hinck AP, Fitzpatrick PF (2014) The solution structure of the regulatory domain of tyrosine hydroxylase. J Mol Biol 426(7):1483\u20131497","journal-title":"J Mol Biol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1903-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1903-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T14:12:00Z","timestamp":1751724720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1903-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1903-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}